Toggle main navigation
News
Insights
Meetings
Multimedia
ASCO AI in Oncology
Subscribe
Search
Close
AI in Oncology
Bladder Cancer
Breast Cancer
Cardio-oncology
CNS Cancers
Colorectal Cancer
Cost of Care
Infectious Diseases
Gastrointestinal Cancer
Genomics/Genetics
Geriatric Oncology
Global Cancer Care
Gynecologic Cancers
Head and Neck Cancer
Health-Care Policy
Hepatobiliary Cancer
Immunotherapy
Kidney Cancer
Leukemia
Lung Cancer
Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes
Neuroendocrine Tumors
Pancreatic Cancer
Prostate Cancer
Sarcoma
Skin Cancer
Survivorship
Thyroid Cancer
Solid Tumors
Hematologic Malignancies
Issues in Oncology
Thyroid Cancer
Advertisement
The ASCO Post
Thyroid Cancer
Thyroid Cancer
International Study Proposes Refined Staging System for Medullary Thyroid Cancer
November 19
3 min read
Researchers have proposed a refined staging system for medullary thyroid cancer that may improve prognostic accuracy and address limitations of the current staging system.
Thyroid Cancer
Selpercatinib, Sacituzumab Govitecan Show Activity in Thyroid Cancer Subtypes
October 30
4 min read
Thyroid Cancer
Dabrafenib Plus Trametinib Improves Progression-Free Survival in
BRAF
V600E–Positive Differentiated Thyroid Cancer
July 27
3 min read
Solid Tumors
FDA Grants Traditional Approval to Selpercatinib for Locally Advanced or Metastatic
RET
Fusion–Positive Solid Tumors
July 14
2 min read
Thyroid Cancer
Thyroid Cancer: Reproductive Lifespan, Hormone Therapy Potentially Linked to Incidence
June 16
2 min read
Thyroid Cancer
Genetic Modification of the AJCC Classification for Papillary Thyroid Cancer
October 7
3 min read
Thyroid Cancer
FDA Removes Vandetanib REMS Program
September 29
1 min read
Latest in Thyroid Cancer
Load More
Advertisement